Raymund A.C. Roos

18.5k total citations · 3 hit papers
294 papers, 13.1k citations indexed

About

Raymund A.C. Roos is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Raymund A.C. Roos has authored 294 papers receiving a total of 13.1k indexed citations (citations by other indexed papers that have themselves been cited), including 232 papers in Cellular and Molecular Neuroscience, 167 papers in Neurology and 118 papers in Molecular Biology. Recurrent topics in Raymund A.C. Roos's work include Genetic Neurodegenerative Diseases (226 papers), Neurological disorders and treatments (132 papers) and Mitochondrial Function and Pathology (83 papers). Raymund A.C. Roos is often cited by papers focused on Genetic Neurodegenerative Diseases (226 papers), Neurological disorders and treatments (132 papers) and Mitochondrial Function and Pathology (83 papers). Raymund A.C. Roos collaborates with scholars based in Netherlands, United Kingdom and United States. Raymund A.C. Roos's co-authors include Sarah J. Tabrizi, Alexandra Dürr, Blair R. Leavitt, Rachael I. Scahill, Douglas R. Langbehn, David Craufurd, G. Bernhard Landwehrmeyer, Julie C. Stout, Ralf Reilmann and Marion L. C. Maat–Schieman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Raymund A.C. Roos

288 papers receiving 12.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data

2009 756 citations Sarah J. Tabrizi, Douglas R. Langbehn et al. profile →
Huntington's disease: a clinical review

2010 707 citations Raymund A.C. Roos profile →
Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data

2013 622 citations Sarah J. Tabrizi, Rachael I. Scahill et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Raymund A.C. Roos Netherlands	61	8.7k	6.9k	5.5k	1.5k	1.4k	294	13.1k
Robert A. Hauser United States	74	6.8k 0.8×	13.7k 2.0×	3.0k 0.5×	1.8k 1.2×	1.5k 1.1×	358	18.9k
Lüdger Schöls Germany	62	8.8k 1.0×	5.1k 0.7×	7.1k 1.3×	633 0.4×	1.1k 0.8×	352	13.2k
Vladimir Kostić Serbia	53	3.4k 0.4×	6.4k 0.9×	1.8k 0.3×	1.0k 0.7×	1.1k 0.8×	369	10.4k
Lawrence I. Golbe United States	41	5.4k 0.6×	12.5k 1.8×	3.2k 0.6×	1.0k 0.7×	4.1k 3.0×	99	15.9k
Kenneth Marek United States	52	3.5k 0.4×	9.9k 1.4×	1.8k 0.3×	1.2k 0.8×	2.0k 1.4×	189	13.5k
Piu Chan China	51	2.7k 0.3×	7.6k 1.1×	2.3k 0.4×	1.1k 0.8×	2.5k 1.8×	189	13.5k
Håkan Widner Sweden	47	5.4k 0.6×	6.2k 0.9×	3.5k 0.6×	455 0.3×	1.2k 0.9×	121	11.3k
Klaus L. Leenders Netherlands	71	6.2k 0.7×	8.2k 1.2×	2.5k 0.5×	1.8k 1.2×	1.4k 1.0×	300	17.3k
G. Bernhard Landwehrmeyer Germany	61	10.3k 1.2×	6.1k 0.9×	6.6k 1.2×	1.0k 0.7×	1.1k 0.8×	255	13.2k
Paolo Barone Italy	71	4.2k 0.5×	12.3k 1.8×	2.0k 0.4×	2.7k 1.8×	1.3k 1.0×	418	17.6k

Countries citing papers authored by Raymund A.C. Roos

Since Specialization

Citations

This map shows the geographic impact of Raymund A.C. Roos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymund A.C. Roos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymund A.C. Roos more than expected).

Fields of papers citing papers by Raymund A.C. Roos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raymund A.C. Roos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymund A.C. Roos. The network helps show where Raymund A.C. Roos may publish in the future.

Co-authorship network of co-authors of Raymund A.C. Roos

This figure shows the co-authorship network connecting the top 25 collaborators of Raymund A.C. Roos. A scholar is included among the top collaborators of Raymund A.C. Roos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raymund A.C. Roos. Raymund A.C. Roos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dekkers, Olaf M., et al.. (2025). Total functioning capacity scale in Huntington's disease: natural course over time. Journal of Neurology. 272(2). 140–140.

Zwet, Erik W. van, et al.. (2025). Comparison of the Clinical Spectrum of Juvenile- and Adult-Onset Huntington Disease. Neurology. 104(10). e213525–e213525.

Estevez‐Fraga, Carlos, André Altmann, Christopher S. Parker, et al.. (2023). Genetic topography and cortical cell loss in Huntington's disease link development and neurodegeneration. Brain. 146(11). 4532–4546. 18 indexed citations

Estevez‐Fraga, Carlos, Rachael I. Scahill, Alexandra Dürr, et al.. (2021). Composite UHDRS Correlates With Progression of Imaging Biomarkers in Huntington's Disease. Movement Disorders. 36(5). 1259–1264. 17 indexed citations

Ciosi, Marc, Alastair Maxwell, Sarah A. Cumming, et al.. (2019). A genetic association study of glutamine-encoding DNA sequence structures, somatic CAG expansion, and DNA repair gene variants, with Huntington disease clinical outcomes. EBioMedicine. 48. 568–580. 101 indexed citations

Roos, Raymund A.C., et al.. (2018). Premanifest Huntington’s disease: Examination of oculomotor abnormalities in clinical practice. PLoS ONE. 13(3). e0193866–e0193866. 10 indexed citations

Reijntjes, Robert, et al.. (2018). Progressive microstructural changes of the occipital cortex in Huntington’s disease. Brain Imaging and Behavior. 12(6). 1786–1794. 11 indexed citations

Roos, Raymund A.C., et al.. (2018). Interrater Reliability of the Unified Huntington's Disease Rating Scale‐Total Motor Score Certification. Movement Disorders Clinical Practice. 5(3). 290–295. 14 indexed citations

Achterberg, Wilco P., et al.. (2018). Assessment Scales for Patients with Advanced Huntington's Disease: Comparison of the UHDRS and UHDRS‐FAP. Movement Disorders Clinical Practice. 5(5). 527–533. 10 indexed citations

10.

Minkova, Lora, Sarah Gregory, Rachael I. Scahill, et al.. (2017). Cross-sectional and longitudinal voxel-based grey matter asymmetries in Huntington's disease. NeuroImage Clinical. 17. 312–324. 24 indexed citations

11.

Quinn, Lori, Mark Kelson, Helen Dawes, et al.. (2016). A randomized, controlled trial of a multi-modal exercise intervention in Huntington’s disease. Parkinsonism & Related Disorders. 31. 46–52. 64 indexed citations

12.

Metzger, Silke, Olaf Rieß, Raymund A.C. Roos, et al.. (2013). The V471A Polymorphism in Autophagy-Related Gene ATG7 Modifies Age at Onset Specifically in Italian Huntington Disease Patients. PLoS ONE. 8(7). e68951–e68951. 41 indexed citations

13.

Aziz, N. Ahmad, et al.. (2009). Increased Hypothalamic-Pituitary-Adrenal Axis Activity in Huntington’s Disease. The Journal of Clinical Endocrinology & Metabolism. 94(4). 1223–1228. 108 indexed citations

14.

Maat–Schieman, Marion L. C., Raymund A.C. Roos, Monique Losekoot, et al.. (2007). Neuronal Intranuclear and Neuropil Inclusions for Pathological Assessment of Huntington’s Disease. Brain Pathology. 17(1). 31–37. 20 indexed citations

15.

Kaptein, Adrian A., Desirée I. Helder, Margreet Scharloo, et al.. (2006). Illness perceptions and coping explain well-being in patients with Huntington's disease. Psychology and Health. 21(4). 431–446. 46 indexed citations

16.

Cong, Shuyan, Barry A. Pepers, Raymund A.C. Roos, Gert‐Jan B. van Ommen, & Josephine C. Dorsman. (2005). Small N-terminal mutant huntingtin fragments, but not wild type, are mainly present in monomeric form: Implications for pathogenesis. Experimental Neurology. 199(2). 257–264. 6 indexed citations

17.

Cong, Shuyan, Barry A. Pepers, Raymund A.C. Roos, Gert‐Jan B. van Ommen, & Josephine C. Dorsman. (2005). Epitope Mapping of Monoclonal Antibody 4C8 Recognizing the Protein Huntingtin. Hybridoma. 24(5). 231–235. 15 indexed citations

18.

Bornebroek, Marjolijn, Peter A. von dem Borne, Joost Haan, et al.. (1998). Binding of amyloid β precursor protein to coagulation factor XIa in vivo may favour haemorrhagic stroke. Journal of Neurology. 245(2). 111–115. 5 indexed citations

19.

Wintzen, Axel R., et al.. (1994). Influence of Bolus Volume on Hyoid Movements in Normal Individuals and Patients with Parkinson's Disease. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 21(1). 57–59. 31 indexed citations

20.

Hoogeveen, A. T., et al.. (1993). Characterization and localization of the Huntington disease gene product. Human Molecular Genetics. 2(12). 2069–2073. 152 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact